Sequent Penems Private Limited, a active private limited company, was established on 10 May 2010 in Bangalore South, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233KA2010PTC053548. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹4.53 Cr.
It upholds a compliant status. Its leadership includes Salim Sadiq Shaikh (Director), Akash Suresh Puranik (Director). Past directors included Gautam Kumar Das, Shridhara Kela, Swaminathan Ramesh. It holds ₹10.00 Cr open charges and ₹90.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Symbio House, No. 1215, 24Th Main, 11Th Cross, Hsr Layout, 1St Sector, Bangalore South, Karnataka, 560102.
U24233KA2010PTC053548
053548
10 May 2010
₹10.00 Cr
₹4.53 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sequent Penems Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Salim Sadiq Shaikh | Director | 25 Apr 2024 | Current |
| Akash Suresh Puranik | Director | 25 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Dec 2010 | Past |
| Pramod Abcsdd | Director | 13 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 14 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Apr 2024 | Past |
| Pramod Abcsdd | Director | 13 May 2019 | Past |
| Pramod Abcsdd | Director | 17 Dec 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sequent Penems Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 53.56% decrease. The company also saw a substantial fall in profitability, with a 101.77% decrease in profit. The company's net worth dipped by a decrease of 0.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sequent Penems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹900,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2024 | Others | ₹10.00 Cr | Open |
| 09 Mar 2012 | State Bank Of Hyderabad | ₹90.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Sequent Penems has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sequent Penems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Penems's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sequent Penems Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100979666 was registered on 12 Sep 2024. was completed.
Progress on Salim Sadiq Shaikh was appointed as a Director was appointed as a Director on 25 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Akash Suresh Puranik was appointed as a Director was appointed as a Director on 25 Apr 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Progress on Sequent Penems Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on A charge registered on 09 Mar 2012 via Charge ID 10352523 with State Bank Of Hyderabad was fully satisfied on 13 May 2014. was documented.
The animal healthcare company also looks to tap into multibillion dollar foreign markets to expand its growth potential..
The CIN of Sequent Penems Private Limited is U24233KA2010PTC053548.
Sequent Penems Private Limited is headquartered at Symbio House, No. 1215, 24Th Main, 11Th Cross, Hsr Layout, 1St Sector, Bangalore South, Karnataka, 560102.
Sequent Penems Private Limited was incorporated on 10 May 2010.
The current directors of Sequent Penems Private Limited are
The primary industry of Sequent Penems Private Limited is Pharma.
Sequent Penems Private Limited is unlisted.
The authorized capital of Sequent Penems Private Limited is ₹10.00 Cr, and the paid-up capital is ₹4.53 Cr.
The compliance status of Sequent Penems Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX